Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure.

Mohl W, Spitzer E, Mader RM, Wagh V, Nguemo F, Milasinovic D, Jusić A, Khazen C, Szodorai E, Birkenberg B, Lubec G, Hescheler J, Serruys PW.

ESC Heart Fail. 2018 Sep 19. doi: 10.1002/ehf2.12354. [Epub ahead of print]

PMID:
30230713
2.

From state-of-the-art cell therapy to endogenous cardiac repair.

Mohl W, Henry TD, Milasinovic D, Nguemo F, Hescheler J, Perin EC.

EuroIntervention. 2017 Aug 25;13(6):760-772. doi: 10.4244/EIJ-D-17-00467. Review.

3.

Closed-loop helium circulation system for actuation of a continuously operating heart catheter pump.

Karabegovic A, Hinteregger M, Janeczek C, Mohl W, Gföhler M.

Int J Artif Organs. 2017 Jun 9;40(6):272-281. doi: 10.5301/ijao.5000593. Epub 2017 May 27.

PMID:
28574110
4.

Azathioprine allows glucocorticoid withdrawal - post hoc results of a prospective study in patients with inflammatory bowel diseases.

Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Siegmund B, Schmidt C, Stallmach A; German IBD Study group.

Z Gastroenterol. 2017 May;55(5):461-465. doi: 10.1055/s-0043-106310. Epub 2017 May 12.

PMID:
28499322
5.

Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.

Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, Maaser C; TRUST study group.

Clin Gastroenterol Hepatol. 2017 Apr;15(4):535-542.e2. doi: 10.1016/j.cgh.2016.10.040. Epub 2016 Nov 14.

PMID:
27856365
6.

Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.

Teich N, Bokemeyer B, Mohl W, Walldorf J, Bruns T, Schmidt C, Stallmach A; German IBD Study Group.

Gut. 2017 Aug;66(8):1531-1532. doi: 10.1136/gutjnl-2016-313138. Epub 2016 Nov 14. No abstract available.

PMID:
27849560
7.

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.

Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Klugmann T, Kruis W, Siegmund B, Helwig U, Weismüller J, Drabik A, Stallmach A; German IBD Study Group.

J Crohns Colitis. 2016 Jan;10(1):61-8. doi: 10.1093/ecco-jcc/jjv188. Epub 2015 Oct 13.

8.

Contemporary perspective on endogenous myocardial regeneration.

Milasinovic D, Mohl W.

World J Stem Cells. 2015 Jun 26;7(5):793-805. doi: 10.4252/wjsc.v7.i5.793. Review.

9.

Transcoronary sinus catheter interventions: back in the repertoire?

Mohl W, Milasinovic D, Maurer G.

EuroIntervention. 2015 May;11(1):19, 21, 23. doi: 10.4244/EIJV11I1A3. No abstract available.

10.

PICSO: from myocardial salvage to tissue regeneration.

Mohl W, Gangl C, Jusić A, Aschacher T, De Jonge M, Rattay F.

Cardiovasc Revasc Med. 2015 Jan-Feb;16(1):36-46. doi: 10.1016/j.carrev.2014.12.004. Epub 2014 Dec 23. Review.

11.

Totally endoscopic congenital heart surgery compared with the traditional heart operation in children.

Cheng Y, Chen H, Mohl W, Liu X, Si Z.

Wien Klin Wochenschr. 2013 Nov;125(21-22):704-8. doi: 10.1007/s00508-013-0438-8. Epub 2013 Oct 23.

12.

Left ventricular pseudoaneurysm following mitral valve repair.

Kasahara H, Beran G, Mohl W.

Gen Thorac Cardiovasc Surg. 2009 Apr;57(4):221-3. doi: 10.1007/s11748-008-0364-2. Epub 2009 Apr 15. Review.

PMID:
19367458
13.

Coronary venous pressure elevation 'risks and benefit'.

Mohl W, Milasinovic D, Steurer G.

Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):E4. doi: 10.1038/ncpcardio1476. No abstract available.

PMID:
19234495
14.

Coronary sinus reducer stent.

Mohl W, Mina S, Milansinovic D, Kasahara H, Yoav P.

J Thorac Cardiovasc Surg. 2008 Nov;136(5):1390. doi: 10.1016/j.jtcvs.2008.01.047. No abstract available.

15.

The legacy of coronary sinus interventions: endogenous cardioprotection and regeneration beyond stem cell research.

Mohl W, Mina S, Milasinovic D, Kasahara H, Wei S.

J Thorac Cardiovasc Surg. 2008 Nov;136(5):1131-5. doi: 10.1016/j.jtcvs.2008.05.034. Review. No abstract available.

16.

Is activation of coronary venous cells the key to cardiac regeneration?

Mohl W, Mina S, Milasinovic D, Kasahara H, Wei S, Maurer G.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):528-30. doi: 10.1038/ncpcardio1298. No abstract available.

PMID:
18679384
17.

Myocardial protection via the coronary sinus.

Mohl W, Komamura K, Kasahara H, Heinze G, Glogar D, Hirayama A, Kodama K.

Circ J. 2008 Apr;72(4):526-33.

18.

Intermittent pressure elevation of the coronary venous system as a method to protect ischemic myocardium.

Mohl W, Kajgana I, Bergmeister H, Rattay F.

Interact Cardiovasc Thorac Surg. 2005 Feb;4(1):66-9. Epub 2004 Dec 17.

PMID:
17670358
19.

Embryonic recall: myocardial regeneration beyond stem cell transplantation.

Mohl W.

Wien Klin Wochenschr. 2007;119(11-12):333-6. No abstract available.

PMID:
17634889
20.

Beck and back: a paradigm change in coronary sinus interventions--pulsatile stretch on intact coronary venous endothelium.

Weigel G, Kajgana I, Bergmeister H, Riedl G, Glogar HD, Gyöngyösi M, Blasnig S, Heinze G, Mohl W.

J Thorac Cardiovasc Surg. 2007 Jun;133(6):1581-7.

Supplemental Content

Loading ...
Support Center